UChicago Medicine Working to Offer Breakthrough CAR T-Cell Gene Therapy Approved Today by FDA


The University of Chicago Medicine is one of a limited number of U.S. sites working to offer a breakthrough gene therapy for pediatric acute lymphoblastic leukemia (ALL), which was just approved by the U.S. Food and Drug Administration.